{{Drugbox
| verifiedrevid = 477317609
| IUPAC_name = ''N''-[(1-Allylpyrrolidin-2-yl)methyl]-6-methoxy-1''H''-benzo[''d''][1,2,3]triazole-5-carboxamide
| image = Alizapride.svg
| image2 = 3D Alizapride.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|alizapride}}
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = [[oral administration|Oral]], [[Intramuscular injection|IM]], [[Intravenous therapy|IV]]
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life = 3 hours
| excretion = [[Kidney|Renal]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 59338-93-1
| ATC_prefix = A03
| ATC_suffix = FA05
| PubChem = 43008
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01425
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 39202
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P55703ZRZY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07102
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 290194
<!--Chemical data-->
| C=16 | H=21
| N=5 | O=2
| molecular_weight = 315.37 g/mol
| smiles = O=C(c2cc1nnnc1cc2OC)NCC3N(C\C=C)CCC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KSEYRUGYKHXGFW-UHFFFAOYSA-N
}}

'''Alizapride''' ('''Litican''', '''Plitican''', '''Superan''', '''Vergentan''') is a [[dopamine antagonist]] with [[prokinetic]] and [[antiemetic]] effects used in the treatment of [[nausea]] and [[vomiting]], including [[postoperative nausea and vomiting]]. It is  structurally related to [[metoclopramide]] and other [[benzamide]]s.<ref>{{cite journal |vauthors =Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M |title=Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial |journal=Cancer Chemother Pharmacol |volume=22 |issue=4 |pages=316â€“20 |year=1988 |pmid=3048762 |doi=10.1007/bf00254238}}</ref>
== References ==
{{Reflist}}

{{Antiemetics}}
{{Propulsives}}
{{Dopaminergics}}

[[Category:Antiemetics]]
[[Category:Dopamine antagonists]]
[[Category:Motility stimulants]]
[[Category:Phenol ethers]]
[[Category:Benzotriazoles]]
[[Category:Benzamides]]
[[Category:Pyrrolidines]]


{{gastrointestinal-drug-stub}}